Scientists hunt for hidden clues to stop nerve disease in its tracks
NCT ID NCT07476365
First seen Mar 22, 2026 · Last updated May 04, 2026 · Updated 6 times
Summary
This study aims to find early biological markers (biomarkers) for Charcot-Marie-Tooth disease type 1A (CMT1A) in people aged 10 to 30. Researchers will analyze blood, skin, and nerve signals from both rats and humans to predict how the disease will progress. No treatment is tested; the goal is to make future clinical trials in children possible by providing reliable ways to measure disease severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre
RECRUITINGGöttingen, 37075, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.